India's Concord Biotech jumps on bonus share issue news
Shares of Indian pharmaceutical firm Concord Biotech rose 4.6% to 1,562.40 rupees, their highest in over three weeks, after its board proposed issuing bonus equity shares. The company's board is set to consider this proposal at a meeting on September 23.
40 rupees, their highest level in more than three weeks. The stock posted its biggest percentage gain since July 31, 2026. The company’s board will consider a proposal to issue bonus equity shares to existing shareholders at a board meeting on September 23. 01%.
com; (+91) 8296756080)